1. Home
  2. WYY vs RANI Comparison

WYY vs RANI Comparison

Compare WYY & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WidePoint Corporation

WYY

WidePoint Corporation

HOLD

Current Price

$10.58

Market Cap

107.8M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.97

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WYY
RANI
Founded
1991
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.8M
126.8M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
WYY
RANI
Price
$10.58
$0.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$8.67
$7.50
AVG Volume (30 Days)
166.3K
1.0M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
0.01
N/A
Revenue
$150,545,364.00
$1,633,000.00
Revenue This Year
$14.41
$274.77
Revenue Next Year
$11.41
$79.44
P/E Ratio
$1,082.00
N/A
Revenue Growth
5.59
58.85
52 Week Low
$2.80
$0.39
52 Week High
$11.16
$3.87

Technical Indicators

Market Signals
Indicator
WYY
RANI
Relative Strength Index (RSI) 62.28 49.28
Support Level $4.59 $0.86
Resistance Level $10.49 $1.10
Average True Range (ATR) 1.05 0.09
MACD 0.02 -0.01
Stochastic Oscillator 78.11 36.96

Price Performance

Historical Comparison
WYY
RANI

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: